Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
IJMDAT (2018) 1:e164
More serious risks are less common but important
Combinational therapy of a VEGFR1 and VEGFR2 peptide-based vaccine with S-1 plus cisplatin provided higher clinical efficacy, and no severe adverse effects were reported in patients with advanced gastric cancer
RainShadow Labs operates a full research and development department, a production and manufacturing center, and an internal quality control laboratory
US$ 27.83
US$ 21.69
US$ 29.21
US$ 23.15
US$ 28.12
US$ 22.53
